Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Merah Putih Vaccine Heading Into Pilot Phase; Clinical Trials Soon

24 November 2021 13:30 WIB

Scientists work in the Merah Putih vaccine research facility of the Bio Farma office in Bandung, Wednesday, August 12, 2020. ANTARA/Dhemas Reviyanto

TEMPO.CO, Jakarta - Airlangga University Surabaya Rector Mohammad Nasih said that PT Biotis Pharmaceuticals Indonesia is producing a pilot scale of the Merah Putih Vaccine using vaccine seeds produced by the campus.

He said to journalists on November 23 that “This is used to inoculate vaccine volunteers,” Antaranews reported. 

Pilot scale production, he added, is a limited production vaccine batch specifically used for the three stages of clinical trials as the first clinical trial is slated for December this year on a small group of volunteers. 

The clinical trials will be permitted to be conducted in parallel with each other once the permit is obtained. This means the more advanced trial can be conducted as the first clinical trial is being finalized. 

“This will progress and hopefully in January 2022 the third clinical trial can be conducted. We are doing it in parallel but there will be gaps in between,” he said.

The Merah Putih vaccine is a live attenuated vaccine where a whole bacteria or virus has been weakened and is injected to people so that they create a protective immune response but do not cause disease in healthy people. 

Read: Merah Putih Vaccine Targeted to Earn EUA by March 2022

ANTARA



BPOM Hopes Merah Putih Vaccine Gets Registered with WHO

28 Juni 2022

BPOM Hopes Merah Putih Vaccine Gets Registered with WHO

BPOM hopes that the indigenous Merah Putih vaccine would be registered with the World Health Organization (WHO)


Merah Putih Vaccine to Be Used as Booster, for Children: Health Minister

10 Februari 2022

Merah Putih Vaccine to Be Used as Booster, for Children: Health Minister

Indonesia's Minister of Health Budi Gunadi Sadikin said homegrown Merah Putih Vaccine will be used as a booster and for children aged 3 to 6 years.


BPOM Allows Clinical Trials on Merah Putih Vaccine

7 Februari 2022

BPOM Allows Clinical Trials on Merah Putih Vaccine

The Food and Drug Monitoring Agency (BPOM) released approval for the implementation of phase I and II clinical trials on the Merah Putih Vaccine.


Merah Putih Vaccine Production Target Delayed, BRIN Researcher Says

25 Januari 2022

Merah Putih Vaccine Production Target Delayed, BRIN Researcher Says

Eijkman former head Amin Soebandrio said the production of the Merah Putih vaccine was delayed by one year from the plan.


Development of Indigenous COVID-19 Vaccine is a Big Challenge: BRIN

16 Januari 2022

Development of Indigenous COVID-19 Vaccine is a Big Challenge: BRIN

Developing the Merah Putih COVID-19 vaccine is a big challenge, says BRIN chief.


BPOM Assists 15 Studies on Herbal Medicines for COVID-19 Treatment

13 Oktober 2021

BPOM Assists 15 Studies on Herbal Medicines for COVID-19 Treatment

The Food and Drug Monitoring Agency (BPOM) is assisting 15 research on herbal medicines that can be used as an additional treatment for COVID-19.


Merah Putih Vaccine Targeted to Earn EUA by March 2022

25 Agustus 2021

Merah Putih Vaccine Targeted to Earn EUA by March 2022

BRIN official Erry Ricardo said Unair and Eijkman are the two leading institutions in the development of the Merah Putih Vaccine.


BRIN Earmarks Rp200 Billion for Merah Putih Vaccine Development

23 Agustus 2021

BRIN Earmarks Rp200 Billion for Merah Putih Vaccine Development

BRIN has spent up to Rp200 billion for the development of the home-grown merah putih vaccine to combat COVID-19.


BPOM Grants GMP Certificate for Merah Putih Vaccine Production

18 Agustus 2021

BPOM Grants GMP Certificate for Merah Putih Vaccine Production

BPOM grants a certificate of Good Manufacturing Practices (GMP) Fill and Finish Facility for the production of Covid-19 vaccine candidates.


Head Researcher Reveals Issues Facing Merah Putih Vaccine Development

18 Agustus 2021

Head Researcher Reveals Issues Facing Merah Putih Vaccine Development

Head of BRIN explains the major challenges facing Indonesia's inaugural home-grown Covid-19 vaccine, the Merah Putih vaccine.